TY - JOUR
T1 - Human complement C3 deficiency: Th1 induction requires T cell-derived complement C3a and CD46 activation
AU - Ghannam, Arije
AU - Fauquert, Jean Luc
AU - Thomas, Caroline
AU - Kemper, Claudia
AU - Drouet, Christian
N1 - Funding Information:
This work was funded by an EU Erare 2007 FP6 grant (HAEIII awarded to CD) and a MRC Research Grant (G1002165 awarded to CK), an EU FP7 IMI BTCURE (CK, lead scientist), the Medical Research Council Centre for Transplantation (supported by the MRC Centre grant no. MR/J006742/1 ), Guy's Hospital, King's College and the Department of Health, National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's & St. Thomas’ NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. AG was supported by grants from the EU Erare FP6 HAEIII Program and the EFS National Annual Research Call (TRALI awarded to CD).
PY - 2014/3
Y1 - 2014/3
N2 - Human T helper type 1 (Th1) responses are essential in defense. Although T cell receptor (TCR) and co-stimulator engagement are indispensable for T cell activation, stimulation of additional receptor pathways are also necessary for effector induction. For example, engagement of the complement regulator CD46 by its ligand C3b generated upon TCR activation is required for IFN-γ production as CD46-deficient patients lack Th1 responses. Utilizing T cells from two C3-deficient patients we demonstrate here that normal Th1 responses also depend on signals mediated by the anaphylatoxin C3a receptor (C3aR). Importantly, and like in CD46-deficient patients, whilst Th1 induction are impaired in C3-deficient patients in vitro, their Th2 responses are unaffected. Furthermore, C3-deficient CD4+ T cells present with reduced expression of CD25 and CD122, further substantiating the growing notion that complement fragments regulate interleukin-2 receptor (IL-2R) assembly and that disturbance of complement-guided IL-2R assembly contributes to aberrant Th1 effector responses. Lastly, sustained intrinsic production of complement fragments may participate in the Th1 contraction phase as both C3a and CD46 engagement regulate IL-10 co-expression in Th1 cells. These data suggest that C3aR and CD46 activation via intrinsic generation of their respective ligands is an integral part of human Th1 (but not Th2) immunity.
AB - Human T helper type 1 (Th1) responses are essential in defense. Although T cell receptor (TCR) and co-stimulator engagement are indispensable for T cell activation, stimulation of additional receptor pathways are also necessary for effector induction. For example, engagement of the complement regulator CD46 by its ligand C3b generated upon TCR activation is required for IFN-γ production as CD46-deficient patients lack Th1 responses. Utilizing T cells from two C3-deficient patients we demonstrate here that normal Th1 responses also depend on signals mediated by the anaphylatoxin C3a receptor (C3aR). Importantly, and like in CD46-deficient patients, whilst Th1 induction are impaired in C3-deficient patients in vitro, their Th2 responses are unaffected. Furthermore, C3-deficient CD4+ T cells present with reduced expression of CD25 and CD122, further substantiating the growing notion that complement fragments regulate interleukin-2 receptor (IL-2R) assembly and that disturbance of complement-guided IL-2R assembly contributes to aberrant Th1 effector responses. Lastly, sustained intrinsic production of complement fragments may participate in the Th1 contraction phase as both C3a and CD46 engagement regulate IL-10 co-expression in Th1 cells. These data suggest that C3aR and CD46 activation via intrinsic generation of their respective ligands is an integral part of human Th1 (but not Th2) immunity.
UR - http://www.scopus.com/inward/record.url?scp=84890070748&partnerID=8YFLogxK
U2 - 10.1016/j.molimm.2013.11.010
DO - 10.1016/j.molimm.2013.11.010
M3 - Journal articles
C2 - 24321396
AN - SCOPUS:84890070748
SN - 0161-5890
VL - 58
SP - 98
EP - 107
JO - Molecular Immunology
JF - Molecular Immunology
IS - 1
ER -